FDA.reportPublic FDA data

dextromethorphan hydrobromide 3 MG/ML / doxylamine succinate 1.25 MG/ML Oral Solution

RxCUI
1371196
RxNorm name
dextromethorphan hydrobromide 3 MG/ML / doxylamine succinate 1.25 MG/ML Oral Solution
Display name
Dextromethorphan/Doxylamine (Oral Liquid)
Full name
dextromethorphan hydrobromide 3 MG/ML / doxylamine succinate 1.25 MG/ML Oral Solution
Term type
SCD
Status
Active
Strength
3-1.25 mg/ml
Dose form
Sol
Route
Oral Liquid
Updated
2026-07-26 07:00:41

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042013
Active start
042013
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
dextromethorphan hydrobromide3 MG / 1 MLdextromethorphandextromethorphan hydrobromide
doxylamine succinate1.25 MG / 1 MLdoxylaminedoxylamine succinate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
dextromethorphan3289
doxylamine3642

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRdextromethorphan hydrobromide 3 MG/ML / doxylamine succinate 1.25 MG/ML Oral Solution1NAMES
RxNorm Namedextromethorphan hydrobromide 3 MG/ML / doxylamine succinate 1.25 MG/ML Oral Solution1NAMES
RxNorm Synonymdextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG per 10 ML Oral Solution1NAMES
TTYSCD1ATTRIBUTES
RxCUI13711961CODES
MMSL_CODE
2 linked values
2CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 19 matching rows.

NDC11, Source, Active table
NDC11SourceActive
46122037534rxnav_ndcsyes
59779014504rxnav_ndcsyes
00031871712rxnav_historical
00031871718rxnav_historical
11673069534rxnav_historical
11822068599rxnav_historical
36800051126rxnav_historical
36800084126rxnav_historical
41520052326rxnav_historical
42507090126rxnav_historical
42507090134rxnav_historical
49580041404rxnav_historical
55319041404rxnav_historical
55910059126rxnav_historical
58602015924rxnav_historical
58602051224rxnav_historical
59779014508rxnav_historical
67091029218rxnav_historical
69842001320rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
901b0a47-2de0-43e8-ba50-4aede9b2cc5fDrug FactsFamily Dollar (FAMILY WELLNESS)20211020
1ae825b9-327e-4d21-a7cc-b65de83ea2baDrug FactsCVS Pharmacy20211014
a0de05fd-505c-4984-8425-b7653fa676b4Drug FactsP & L Development, LLC20201207
3f183c1b-2266-4854-a3ef-a35bd5d01825Amerisource Bergen Tussin DM MAX Drug FactsAmerisource Bergen20201204
c4e0616a-6782-41f9-aaad-007c23b29bbfAurohealth LLC20191205
174a02b3-ad34-42b5-9115-309641dd6185CVS Pharmacy, Inc. | Aurohealth LLC20191130
6e2f7caa-e150-4c93-a60f-3f0964e9e362Drug FactsAurohealth LLC20191128
d79e3404-9080-462f-8be6-2828cbef5174Drug FactsWinCo Foods, LLC20191002
1e0dbdf2-60a4-45dd-a2aa-80160b1abab2Dolgencorp, LLC Tussin Drug FactsDolgencorp, LLC20181219
32f9202f-4c78-4dca-9633-819253aef349Target Corporation Nighttime Cough Control Drug FactsTarget Corporation20181216
cf15bc0f-bed8-4b0a-aaaf-b7f8fc32e1baTopco Associates LLC. Tussin DM Drug FactsTopco Associates LLC20181210
bf160db4-36e9-4cf6-a213-ff4047afd02bTopco Associates LLC. Tussin DM Max Drug FactsTopco Associates LLC20180220
fc24c7a5-8043-4012-9b53-b14d34b9da13American Sales Company Tussin DM Drug FactsAmerican Sales Company20170819
e64d9ff3-9c11-4a4a-923f-853a33ac6427Drug FactsAurohealth LLC20160502

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR06AAAminoalkyl ethersATC1-4doxylamine
ATCR05DAOpium alkaloids and derivativesATC1-4dextromethorphan
FDASPLN0000175750AntihistamineEPChas_epcdoxylamine
FDASPLN0000182149Sigma-1 AgonistEPChas_epcdextromethorphan
FDASPLN0000181821Uncompetitive N-methyl-D-aspartate Receptor AntagonistEPChas_epcdextromethorphan
FDASPLN0000000207Histamine Receptor AntagonistsMOAhas_moadoxylamine
FDASPLN0000182147Sigma-1 Receptor AgonistsMOAhas_moadextromethorphan
FDASPLN0000181819Uncompetitive NMDA Receptor AntagonistsMOAhas_moadextromethorphan
MEDRTD003915DextromethorphanCHEMhas_ingredientdextromethorphan hydrobromide
MEDRTD003915DextromethorphanCHEMhas_ingredientdextromethorphan
MEDRTD004319DoxylamineCHEMhas_ingredientdoxylamine
MEDRTD004319DoxylamineCHEMhas_ingredientdoxylamine succinate
MEDRTD003371CoughDISEASEmay_treatdextromethorphan hydrobromide
MEDRTD003371CoughDISEASEmay_treatdextromethorphan
MEDRTD003371CoughDISEASEmay_preventdextromethorphan
MEDRTD003371CoughDISEASEmay_preventdextromethorphan hydrobromide
MEDRTD004342Drug HypersensitivityDISEASEci_withdextromethorphan
MEDRTD004342Drug HypersensitivityDISEASEci_withdextromethorphan hydrobromide
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxylamine succinate
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxylamine
MEDRTD006261HeadacheDISEASEmay_treatdoxylamine succinate
MEDRTD006261HeadacheDISEASEmay_treatdoxylamine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatdoxylamine succinate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatdoxylamine
MEDRTD007319Sleep Initiation and Maintenance DisordersDISEASEmay_treatdoxylamine succinate
MEDRTD007319Sleep Initiation and Maintenance DisordersDISEASEmay_treatdoxylamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadoxylamine succinate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadoxylamine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moadextromethorphan hydrobromide
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moadextromethorphan
MEDRTN0000000109Serotonin Uptake InhibitorsMOAhas_moadextromethorphan hydrobromide
MEDRTN0000000109Serotonin Uptake InhibitorsMOAhas_moadextromethorphan
MEDRTN0000182147Sigma-1 Receptor AgonistsMOAhas_moadextromethorphan
MEDRTN0000182147Sigma-1 Receptor AgonistsMOAhas_moadextromethorphan hydrobromide
MEDRTN0000181819Uncompetitive NMDA Receptor AntagonistsMOAhas_moadextromethorphan hydrobromide
MEDRTN0000181819Uncompetitive NMDA Receptor AntagonistsMOAhas_moadextromethorphan
MEDRTN0000008657Decreased Histamine ActivityPEhas_pedoxylamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pedoxylamine succinate
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_pedextromethorphan hydrobromide
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_pedextromethorphan

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH3 MG/ML / 1.25 MG/ML (expressed as doxylamine succinate)
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESVUID4035131
NAMESPrescribable Synonymdextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 10 mL Oral Solution
SOURCESSourceGold Standard Alchemy
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File